These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 22361816

  • 1. Targeting dendritic cells with antigen via dendritic cell-associated promoters.
    Moulin V, Morgan ME, Eleveld-Trancikova D, Haanen JB, Wielders E, Looman MW, Janssen RA, Figdor CG, Jansen BJ, Adema GJ.
    Cancer Gene Ther; 2012 May; 19(5):303-11. PubMed ID: 22361816
    [Abstract] [Full Text] [Related]

  • 2. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK, Stephani J, Schaefer M, Kalay H, García-Vallejo JJ, den Haan J, Saeland E, Sparwasser T, van Kooyk Y.
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [Abstract] [Full Text] [Related]

  • 3. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.
    Unger WW, van Beelen AJ, Bruijns SC, Joshi M, Fehres CM, van Bloois L, Verstege MI, Ambrosini M, Kalay H, Nazmi K, Bolscher JG, Hooijberg E, de Gruijl TD, Storm G, van Kooyk Y.
    J Control Release; 2012 May 30; 160(1):88-95. PubMed ID: 22366522
    [Abstract] [Full Text] [Related]

  • 4. In vivo targeting of human DC-SIGN drastically enhances CD8⁺ T-cell-mediated protective immunity.
    Hesse C, Ginter W, Förg T, Mayer CT, Baru AM, Arnold-Schrauf C, Unger WW, Kalay H, van Kooyk Y, Berod L, Sparwasser T.
    Eur J Immunol; 2013 Oct 30; 43(10):2543-53. PubMed ID: 23784881
    [Abstract] [Full Text] [Related]

  • 5. Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin.
    Ross R, Sudowe S, Beisner J, Ross XL, Ludwig-Portugall I, Steitz J, Tüting T, Knop J, Reske-Kunz AB.
    Gene Ther; 2003 Jun 30; 10(12):1035-40. PubMed ID: 12776161
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
    Tüting T, Steitz J, Brück J, Gambotto A, Steinbrink K, DeLeo AB, Robbins P, Knop J, Enk AH.
    J Gene Med; 1999 Jun 30; 1(6):400-6. PubMed ID: 10753065
    [Abstract] [Full Text] [Related]

  • 7. Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence.
    Ni J, Nolte B, Arnold A, Fournier P, Schirrmacher V.
    Vaccine; 2009 Sep 04; 27(40):5480-7. PubMed ID: 19616491
    [Abstract] [Full Text] [Related]

  • 8. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy.
    van Broekhoven CL, Parish CR, Demangel C, Britton WJ, Altin JG.
    Cancer Res; 2004 Jun 15; 64(12):4357-65. PubMed ID: 15205352
    [Abstract] [Full Text] [Related]

  • 9. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity].
    Tan XH, Wan YH.
    Zhonghua Yi Xue Za Zhi; 2007 Feb 06; 87(6):399-403. PubMed ID: 17456382
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models.
    Kretz-Rommel A, Qin F, Dakappagari N, Torensma R, Faas S, Wu D, Bowdish KS.
    J Immunother; 2007 Oct 06; 30(7):715-26. PubMed ID: 17893564
    [Abstract] [Full Text] [Related]

  • 13. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S, Yuan J, Xiang J.
    J Leukoc Biol; 2007 Oct 06; 82(4):829-38. PubMed ID: 17626150
    [Abstract] [Full Text] [Related]

  • 14. Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.
    Sun JB, Eriksson K, Li BL, Lindblad M, Azem J, Holmgren J.
    Clin Immunol; 2004 Jul 06; 112(1):35-44. PubMed ID: 15207780
    [Abstract] [Full Text] [Related]

  • 15. Immortalized dendritic cell line with efficient cross-priming ability established from transgenic mice harboring the temperature-sensitive SV40 large T-antigen gene.
    Ebihara S, Endo S, Ito K, Ito Y, Akiyama K, Obinata M, Takai T.
    J Biochem; 2004 Sep 06; 136(3):321-8. PubMed ID: 15598888
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H, Wang S, Zhang D, Hou S, Qian W, Li B, Guo H, Kou G, He J, Wang H, Guo Y.
    Clin Cancer Res; 2009 Jul 15; 15(14):4612-21. PubMed ID: 19584156
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice.
    Hattori Y, Kawakami S, Suzuki S, Yamashita F, Hashida M.
    Biochem Biophys Res Commun; 2004 May 14; 317(4):992-9. PubMed ID: 15094367
    [Abstract] [Full Text] [Related]

  • 20. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide].
    Zhang W, He L, Cao X.
    Zhonghua Yi Xue Za Zhi; 1999 Mar 14; 79(3):170-3. PubMed ID: 11601032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.